Takeda Pharmaceutical Co (NYSE:TAK) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Takeda Pharmaceutical Co (TAK) operate in?

Takeda Pharmaceutical Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Takeda Pharmaceutical Co Stock (NYSE: TAK) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 1.75M
Day Range	- - -
52 Wk Range	12.58 - 15.08
Market Cap	$42.17B
P/E Ratio	22.68
Dividend Yield	4.37%
Exchange	NYSE
RSI	34
Short Interest	0.19%
Days to Cover	4.23

Recent News

AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients

AC Immune reports interim results from Phase 2 trial of ACI-7104.056 active immunotherapy for early Parkinson's disease.

Vandana Singh

Urgency, Debate Mark COP29 As Leaders Push For Carbon Market Rules, Worry About Trump

Global leaders gather at COP29 to address climate change, carbon market mechanisms, and climate finance. Urgency and controversy at a fossil fuel reliant host country, but focus on establishing rules for a global carbon market.

Stjepan Kalinic

Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside

HC Wainwright has initiated coverage on Alumis, highlighting the biopharmaceutical company's lead drug candidate, ESK-001. The analyst notes ESK-001's superior clinical data compared to Bristol Myers Squibb's Sotyktu, indicating strong growth potential in the TYK2 market.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 1.75M
Day Range	- - -
52 Wk Range	12.58 - 15.08
Market Cap	$42.17B
P/E Ratio	22.68
Dividend Yield	4.37%
Exchange	NYSE
RSI	34
Short Interest	0.19%
Days to Cover	4.23

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Takeda Pharmaceutical Co (TAK) stock?

You can purchase shares of Takeda Pharmaceutical Co (NYSE:TAK) through any online brokerage.

View our list of the best stock brokerages

Who are Takeda Pharmaceutical Co (TAK) competitors?

Other companies in Takeda Pharmaceutical Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).

What is the forecast, or price target, for Takeda Pharmaceutical Co (TAK) stock?

Takeda Pharmaceutical Co has a consensus price target of $21.33.

What is the current price for Takeda Pharmaceutical Co (TAK)?

The stock price for Takeda Pharmaceutical Co (NYSE: TAK) is $13.3 last updated November 22, 2024 at 9:30 AM EST.

Does Takeda Pharmaceutical Co (TAK) pay a dividend?

There are no upcoming dividends for Takeda Pharmaceutical Co.

When is Takeda Pharmaceutical Co (NYSE:TAK) reporting earnings?

Takeda Pharmaceutical Co’s Q3 earnings are confirmed for Thursday, January 30, 2025.

Is Takeda Pharmaceutical Co (TAK) going to split?

There is no upcoming split for Takeda Pharmaceutical Co.

What sector and industry does Takeda Pharmaceutical Co (TAK) operate in?

Takeda Pharmaceutical Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Comments

Takeda Pharmaceutical Co

Takeda Pharmaceutical Co (TAK) Forecast